Scholarship overview

  • Degree level

    Postgraduate taught

  • Value

    1 x £14,000 to cover 100% Home fees and 1 x £7,000 to cover 50% Home fees

  • Number of awards

    2

  • Academic year

    2024/2025

  • Tuition fee status

    Home

  • Mode of study

    Full time, Part time

  • Available to

    Prospective students

  • Application deadline

    31/05/2024 Closed

  • Additional information

    Scholarship page

    noveltherapies@imperial.ac.uk

  • Available to applicants in the following departments

    • National Heart and Lung Institute

Eligibility criteria

These awards are open to new Home students (UK and Ireland only) making an application to the MSc Genes Drugs and Stem Cells programme to start in 2024.

The focus of these scholarships is to increase access to postgraduate study at Imperial for people from under represented groups. You can see further guidance on the Office for Students webpages on who may be considered an under represented group in Higher Education - https://www.officeforstudents.org.uk/advice-and-guidance/promoting-equal-opportunities/access-and-participation-glossary/#:~:text=Programme%20(NCOP).-,Underrepresented%20groups,income%20or%20low%20socioeconomic%20status

It is not essential for applicants to have already received an offer of a place on a programme, but the initial programme application must have been started before applying for a scholarship

Please note: This scholarship is not available to continuing students.

Course specific information

Genes, Drugs and Stem Cells applicants: https://www.imperial.ac.uk/study/courses/postgraduate-taught/2024/genes-drugs-stem-cells/

Application process

Applications should be submitted through our application form: https://forms.office.com/Pages/ResponsePage.aspx?id=B3WJK4zudUWDC0-CZ8PTB6obiTmbPkZPgiPriNwQpVxUOVI4UEw5MUVXSkY0UVZFSUkxM1Y0SktBQi4u

You will be asked to provide a personal statement outlining why you want to study with us and what you aspire to do on completion of the MSc.

Contact

If you have any additional questions, please contact us at noveltherapies@imperial.ac.uk.